ZNTL compared with LPCN: revenue, margins and what each company keeps, and the suppliers and customers both name

ZNTLZentalis Pharmaceuticals, Inc.

Mkt capRevenueRevenue

LPCNLipocine Inc.

Mkt capRevenueRevenue

Compare

ZNTLZentalis Pharmaceuticals, Inc.

LPCNLipocine Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ZNTL 5

PFEPfizersupplier

IMNMImmunomecustomer

GSKGSKsupplier

—Dana‑Farber Cancer Instituteunlistedsupplier

1 more · ZNTL chain ›

Shared 0

No disclosed counterparties: LPCN.

Only LPCN 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

ZNTLZentalis Pharmaceuticals, Inc.

1.70▼−3.14%· post 1.70

Mkt cap$126.1MRevenue$27MQ4 FY24Revenue—

LPCNLipocine Inc.

1.57▲+8.86%· post 1.57

After hoursNov 5 '26

Mkt cap$15.9MRevenue$2MQ3 FY26Revenue$2MFY25

Compare

After hoursNov 5 '26

ZNTLZentalis Pharmaceuticals, Inc.

LPCNLipocine Inc.

1.70▼−3.14%post 1.70

Price

1.57▲+8.86%post 1.57

$126.1M

Mkt cap

$15.9M

Q4 FY24$27M

Revenue

$2MQ3 FY26

—

Revenue

$2MFY25

ZNTL1.70▼−3.14%vsLPCN1.57▲+8.86%After hoursNov 5 '26